Gentium, a biopharmaceutical company, has promoted Salvatore Calabrese, senior vice president (SVP), finance, to chief financial officer (CFO). Calabrese will continue to retain his title as SVP.
Calabrese joined the company in February 2005 as vice president, finance and secretary and was promoted to SVP, finance in February 2010. Prior to joining the company, Calabrese worked as an accounting and finance manager for Novuspharma, a subsidiary of Cell Therapeutics, that focusses on the discovery and development of cancer drugs.
Prior to this, Calabrese was a manager for PricewaterhouseCoopers (PwC), where he was employed for seven years working in Milan, Italy and Boston, MA.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.